The store will not work correctly when cookies are disabled.
2-(4-chlorophenyl)-5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazole
ID: ALA3099516
PubChem CID: 72947075
Max Phase: Preclinical
Molecular Formula: C24H17ClN4O
Molecular Weight: 412.88
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(-c2nnc(-c3ccc(Cl)cc3)o2)c(-c2ccccc2)nn1-c1ccccc1
Standard InChI: InChI=1S/C24H17ClN4O/c1-16-21(24-27-26-23(30-24)18-12-14-19(25)15-13-18)22(17-8-4-2-5-9-17)28-29(16)20-10-6-3-7-11-20/h2-15H,1H3
Standard InChI Key: HHJOHXOYBPTTBV-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
12.2410 -18.7788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4238 -18.7747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1673 -19.5506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8260 -20.0344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4895 -19.5573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8212 -20.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1098 -21.2530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1054 -22.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8116 -22.4824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5237 -22.0729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5246 -21.2579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2654 -19.8137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9490 -18.1131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2869 -17.3678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8106 -16.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9966 -16.7857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6611 -17.5354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1393 -18.1954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7242 -18.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5413 -18.1271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7978 -17.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1391 -16.8674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4756 -17.3445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5765 -17.1032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1809 -17.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9588 -17.4069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1334 -16.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5240 -16.0569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7485 -16.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9115 -16.3580 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 6 1 0
5 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
2 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
1 19 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
21 24 1 0
27 30 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 412.88 | Molecular Weight (Monoisotopic): 412.1091 | AlogP: 6.22 | #Rotatable Bonds: 4 |
Polar Surface Area: 56.74 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.31 | CX LogP: 5.93 | CX LogD: 5.93 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.35 | Np Likeness Score: -1.37 |
References
1. Ningaiah S, Bhadraiah UK, Doddaramappa SD, Keshavamurthy S, Javarasetty C.. (2014) Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation., 24 (1): [PMID:24316123] [10.1016/j.bmcl.2013.11.029] |